DE2927672C2 - - Google Patents
Info
- Publication number
- DE2927672C2 DE2927672C2 DE2927672A DE2927672A DE2927672C2 DE 2927672 C2 DE2927672 C2 DE 2927672C2 DE 2927672 A DE2927672 A DE 2927672A DE 2927672 A DE2927672 A DE 2927672A DE 2927672 C2 DE2927672 C2 DE 2927672C2
- Authority
- DE
- Germany
- Prior art keywords
- carnitinamide
- solution
- camphorate
- hydrochloride
- column
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- KWIXGIMKELMNGH-ZCFIWIBFSA-O (R)-carnitinamide Chemical compound C[N+](C)(C)C[C@H](O)CC(N)=O KWIXGIMKELMNGH-ZCFIWIBFSA-O 0.000 claims description 31
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 23
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 18
- LSPHULWDVZXLIL-LDWIPMOCSA-N (?)-Camphoric acid Chemical compound CC1(C)[C@@H](C(O)=O)CC[C@@]1(C)C(O)=O LSPHULWDVZXLIL-LDWIPMOCSA-N 0.000 claims description 10
- 239000003456 ion exchange resin Substances 0.000 claims description 7
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 5
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 4
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims description 2
- 239000000243 solution Substances 0.000 description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- -1 D, L-carnitine nitrile Chemical class 0.000 description 6
- KWIXGIMKELMNGH-UHFFFAOYSA-O carnitinamide Chemical compound C[N+](C)(C)CC(O)CC(N)=O KWIXGIMKELMNGH-UHFFFAOYSA-O 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 229960004203 carnitine Drugs 0.000 description 5
- 239000002585 base Substances 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000003287 optical effect Effects 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000007790 solid phase Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- JXXCENBLGFBQJM-FYZOBXCZSA-N [(2r)-3-carboxy-2-hydroxypropyl]-trimethylazanium;chloride Chemical compound [Cl-].C[N+](C)(C)C[C@H](O)CC(O)=O JXXCENBLGFBQJM-FYZOBXCZSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 230000006340 racemization Effects 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- JXXCENBLGFBQJM-UHFFFAOYSA-N (3-carboxy-2-hydroxypropyl)-trimethylazanium;chloride Chemical compound [Cl-].C[N+](C)(C)CC(O)CC(O)=O JXXCENBLGFBQJM-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 229930007886 (R)-camphor Natural products 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012670 alkaline solution Substances 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- PHIQHXFUZVPYII-UHFFFAOYSA-N carnitine Chemical compound C[N+](C)(C)CC(O)CC([O-])=O PHIQHXFUZVPYII-UHFFFAOYSA-N 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229940100890 silver compound Drugs 0.000 description 1
- 150000003379 silver compounds Chemical class 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical class [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT50222/78A IT1156852B (it) | 1978-07-10 | 1978-07-10 | Procedimento industriale per la preparazione del d'canforato della l carnitinammide e del d canforato della d carnitinammide e sue applicazioni |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE2927672A1 DE2927672A1 (de) | 1980-01-31 |
| DE2927672C2 true DE2927672C2 (en, 2012) | 1989-06-01 |
Family
ID=11272520
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19792927672 Granted DE2927672A1 (de) | 1978-07-10 | 1979-07-09 | Verfahren zur herstellung des d-kampferats von l-carnitinamid und des d-kampferats von d-carnitinamid |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US4254053A (en, 2012) |
| JP (1) | JPS5513299A (en, 2012) |
| AT (1) | AT370086B (en, 2012) |
| AU (1) | AU526044B2 (en, 2012) |
| BE (1) | BE877609A (en, 2012) |
| CA (1) | CA1117977A (en, 2012) |
| CH (1) | CH643236A5 (en, 2012) |
| DE (1) | DE2927672A1 (en, 2012) |
| DK (1) | DK149842C (en, 2012) |
| ES (1) | ES482327A1 (en, 2012) |
| FR (1) | FR2430930A1 (en, 2012) |
| GB (1) | GB2025412B (en, 2012) |
| GR (1) | GR69678B (en, 2012) |
| IE (1) | IE48908B1 (en, 2012) |
| IL (1) | IL57745A (en, 2012) |
| IT (1) | IT1156852B (en, 2012) |
| LU (1) | LU81482A1 (en, 2012) |
| NL (1) | NL190755C (en, 2012) |
| NO (1) | NO150879C (en, 2012) |
| SE (1) | SE446264B (en, 2012) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH648287A5 (de) * | 1981-01-21 | 1985-03-15 | Lonza Ag | Verfahren zur herstellung von carnitinamid. |
| CH658857A5 (de) * | 1984-04-04 | 1986-12-15 | Lonza Ag | Optisch aktives di-(3-chlor-2-oxy-propyltrimethylammonium)-tartrat. |
| GB2195630B (en) * | 1986-08-26 | 1990-07-18 | Chuo Kaseihin Co Inc | Method for producing carnitine, l-carnitineamide hydrolase and method for producing same |
| JP2588930B2 (ja) * | 1988-05-13 | 1997-03-12 | 鐘淵化学工業株式会社 | カルニチンの製造方法 |
| JP2581156B2 (ja) * | 1988-05-26 | 1997-02-12 | 日立電子エンジニアリング株式会社 | レーザ共振器のレーザパワー密度測定方式 |
| IT1256705B (it) * | 1992-12-21 | 1995-12-12 | Sigma Tau Ind Farmaceuti | Procedimento per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione. |
| IT1261230B (it) * | 1993-04-08 | 1996-05-09 | Sigma Tau Ind Farmaceuti | Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da suoi precursori aventi opposta configurazione. |
| KR100255039B1 (ko) | 1997-07-28 | 2000-05-01 | 박영구 | L-카르니틴의제조방법 |
| CA2383814C (en) * | 1999-09-03 | 2010-08-17 | Sigma-Tau Healthscience S.P.A. | Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same |
| US20070087975A1 (en) * | 2005-10-17 | 2007-04-19 | Sigma-Tau Industrie Farmaceutiche Riunite Spa | Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients |
| EP1852416A1 (en) * | 2006-05-04 | 2007-11-07 | Universita'degli Studi Di Milano | Enantiomeric resolution of a carnitinamide salt by preferential crystallization |
| KR101097006B1 (ko) | 2006-11-09 | 2011-12-20 | 미츠비시 레이온 가부시키가이샤 | 베타인의 제조 방법 |
| JP2008231046A (ja) * | 2007-03-22 | 2008-10-02 | Mitsubishi Rayon Co Ltd | 光学活性カルニチンアミドハロゲン化物の精製方法 |
| EP2353596A1 (en) | 2010-02-02 | 2011-08-10 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Combination composition, comprising as active ingredients L-carnitine or propionyl L-carnitine, for the prevention or treatment of chronic venous insufficiency |
| EP2363126A1 (en) | 2010-03-04 | 2011-09-07 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Composition comprising as active ingredient L-carnitine in combination with hydroxykynurenine-O-beta-DL-glucoside, for the prevention and/or treatment of pathologies of the eye due to ultraviolet radiation |
| PL2582368T3 (pl) | 2010-06-16 | 2018-08-31 | Alfasigma S.P.A. | Acetylo-karnityna do zastosowania w sposobie zwiększania neurogenezy w tkance nerwowej |
| US9114120B2 (en) | 2010-11-22 | 2015-08-25 | Sigma-Tau Industrie Farmaceutiche Riunite, S.P.A. | Therapeutical method for the treatment of the Leber optic neuropathy |
| EP2648717A1 (en) | 2010-12-09 | 2013-10-16 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Composition for topical use for treating skin disorders |
| EP2586438A1 (en) | 2011-10-28 | 2013-05-01 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Compound useful for preventing cognitive deficit disorders in a new born from HIV-seropositive pregnant female who is in treatment with azidothymidine |
| EP2783695A1 (en) | 2013-03-28 | 2014-10-01 | SIGMA-TAU Industrie Farmaceutiche Riunite S.p.A. | Physiological supplement or medicament for ophthalmic use containing L-carnitine or alkanoyl L-carnitines in combination with eledoisin |
| TN2016000198A1 (en) | 2013-12-05 | 2017-10-06 | Alfasigma Spa | Composition useful for promoting female fertility. |
| JP6887252B2 (ja) | 2014-07-03 | 2021-06-16 | ナン グローバル，エルエルシー | 肥満の治療、重量増加の予防、重量減少の促進、スリミングの促進、又は糖尿病の進行の治療若しくは予防のための方法及び組成物 |
| CN117185945B (zh) * | 2023-08-30 | 2025-08-01 | 湖北楚维药业有限公司 | 一种乙酰左旋肉碱盐酸盐的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE659194A (en, 2012) * | 1965-02-03 | 1965-08-03 | ||
| BE660039A (en, 2012) * | 1965-02-22 | 1965-08-23 | ||
| US3632623A (en) * | 1967-11-21 | 1972-01-04 | Basf Ag | Beta-carbamyl-beta-hydroxyethyl)-alkylammonium salts |
-
1978
- 1978-07-10 IT IT50222/78A patent/IT1156852B/it active
-
1979
- 1979-07-06 AT AT0473779A patent/AT370086B/de not_active IP Right Cessation
- 1979-07-06 US US06/055,238 patent/US4254053A/en not_active Expired - Lifetime
- 1979-07-09 DK DK288679A patent/DK149842C/da not_active IP Right Cessation
- 1979-07-09 NO NO792281A patent/NO150879C/no unknown
- 1979-07-09 ES ES482327A patent/ES482327A1/es not_active Expired
- 1979-07-09 GB GB7923856A patent/GB2025412B/en not_active Expired
- 1979-07-09 NL NL7905349A patent/NL190755C/xx not_active IP Right Cessation
- 1979-07-09 IL IL57745A patent/IL57745A/xx not_active IP Right Cessation
- 1979-07-09 SE SE7905968A patent/SE446264B/sv not_active IP Right Cessation
- 1979-07-09 CA CA000331403A patent/CA1117977A/en not_active Expired
- 1979-07-09 GR GR59544A patent/GR69678B/el unknown
- 1979-07-09 AU AU48780/79A patent/AU526044B2/en not_active Ceased
- 1979-07-09 DE DE19792927672 patent/DE2927672A1/de active Granted
- 1979-07-09 CH CH639779A patent/CH643236A5/it not_active IP Right Cessation
- 1979-07-10 JP JP8800479A patent/JPS5513299A/ja active Granted
- 1979-07-10 FR FR7917828A patent/FR2430930A1/fr active Granted
- 1979-07-10 LU LU81482A patent/LU81482A1/xx unknown
- 1979-07-10 BE BE0/196230A patent/BE877609A/xx not_active IP Right Cessation
- 1979-08-08 IE IE1310/79A patent/IE48908B1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| IT7850222A0 (it) | 1978-07-10 |
| IE48908B1 (en) | 1985-06-12 |
| NL7905349A (nl) | 1980-01-14 |
| GB2025412B (en) | 1983-03-02 |
| CH643236A5 (it) | 1984-05-30 |
| AT370086B (de) | 1983-02-25 |
| LU81482A1 (fr) | 1979-10-31 |
| DE2927672A1 (de) | 1980-01-31 |
| ES482327A1 (es) | 1980-04-01 |
| IE791310L (en) | 1980-01-10 |
| NL190755B (nl) | 1994-03-01 |
| DK149842C (da) | 1987-06-15 |
| SE446264B (sv) | 1986-08-25 |
| NO792281L (no) | 1980-01-11 |
| FR2430930A1 (fr) | 1980-02-08 |
| ATA473779A (de) | 1982-07-15 |
| US4254053A (en) | 1981-03-03 |
| JPS5513299A (en) | 1980-01-30 |
| NO150879C (no) | 1985-01-09 |
| IT1156852B (it) | 1987-02-04 |
| BE877609A (fr) | 1979-11-05 |
| IL57745A (en) | 1982-03-31 |
| AU526044B2 (en) | 1982-12-16 |
| CA1117977A (en) | 1982-02-09 |
| NL190755C (nl) | 1994-08-01 |
| JPS6320217B2 (en, 2012) | 1988-04-26 |
| FR2430930B1 (en, 2012) | 1983-12-23 |
| AU4878079A (en) | 1980-01-17 |
| DK288679A (da) | 1980-01-11 |
| DK149842B (da) | 1986-10-13 |
| SE7905968L (sv) | 1980-01-11 |
| GB2025412A (en) | 1980-01-23 |
| NO150879B (no) | 1984-09-24 |
| GR69678B (en, 2012) | 1982-07-07 |
| IL57745A0 (en) | 1979-11-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2927672C2 (en, 2012) | ||
| DE60100321T2 (de) | Verfahren zur Herstellung von 11-Amino-3-chlor-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c,f][1,2]-thiazepin und Anwendung zur Synthese von Thianeptin | |
| EP0312726B1 (de) | Optisch aktive Salze aus einem substituierten Thiazolidin-4-carboxylat und 3-Chlor-2-hydroxypropyltrimethylammonium, deren Herstellung und Verwendung | |
| DE69912773T2 (de) | Nicht hydratisiertes gabapentin polymorph, herstellungsprozess und verwendung zur herstellung von gabapentin pharmazeutischer reinheit. | |
| EP0157315B1 (de) | Optisch aktives Di-(3-chlor-2-oxy-propyltrimethylammonium)-tartrat | |
| DE69010405T2 (de) | Verfahren zur Herstellung von R(+)-Aminocarnitin und S(-)-Aminocarnitin. | |
| EP0012298B1 (de) | Verfahren zur Reindarstellung von Kaliumribonat und Ribonolacton | |
| DE2501957C2 (de) | Verfahren zur Gewinnung von optisch aktivem p-Hydroxyphenylglycin | |
| DE69229677T2 (de) | Verfahen zur herstellung von (s)(+)-4, 4'-(1-methyl-1,2-ethandiyl)-bis(2,6-piperazindion | |
| EP0090087B1 (de) | Verfahren zur Gewinnung von S-(Carboxymethyl)-(R)-cystein und S-(Carboxymethyl)-(S)-cystein | |
| DE1543811B1 (de) | Verfahren zur Trennung von racemischem Carnitinnitril in seine optisch aktiven Antipoden | |
| DE69030774T2 (de) | Optisch aktive Diastereoisomersalze von Tetrahydro-2-furancarbonsäure | |
| DE3543021C2 (en, 2012) | ||
| DE2350610C3 (de) | DL-Lithiumpantoat, D (+)-üthiumpantoat, L (-)-Lithiumpantoat und Verfahren zur Herstellung der optischen Antipoden des Pantolactons | |
| DE2612615C2 (de) | Verfahren zur Gewinnung von optisch aktivem α-Phenylglycin und Zwischenprodukte dafür | |
| DE2309899C2 (de) | Verfahren zum Abtrennen von Cephalosporin C aus rohen wäßrigen Lösungen | |
| DE2710504A1 (de) | Verfahren zur herstellung von optisch aktivem phenylglycin | |
| DE2421291C2 (de) | Verfahren zur optischen Spaltung von DL-Lysin-(p-aminobenzolsulfonat) | |
| EP0359043A1 (de) | Verfahren zur Isolierung von 2-Keto-polyphydroxy-C6-carbonsäuren, insbesondere von 2-Keto-L-gulonsäure aus wässrigen Fermentationsausträgen | |
| DE2605567C3 (de) | Verfahren zur Gewinnung von optisch aktivem a Phenylglycin-hydrochlorid | |
| DE2227504C3 (de) | Verfahren zur Herstellung von trans-4-Aminomethylcyclohexan-i-carbonsäure oder deren Salzen | |
| DE1695894B2 (de) | Verfahren zur Herstellung von D- und L-Prolin | |
| EP0073052B1 (de) | Verfahren zur Trennung des Racemats S-(Carboxymethyl)-(RS)-cystein (A) | |
| DE3833972A1 (de) | Derivate der 2-pyrrolidon-5-carbonsaeure und verfahren zu ihrer gewinnung | |
| DE1593817C3 (de) | Verfahren zur optischen Aufspaltung von Calciumpantothenat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8128 | New person/name/address of the agent |
Representative=s name: EITLE, W., DIPL.-ING. HOFFMANN, K., DIPL.-ING. DR. |
|
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination | ||
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |